External broker reports(aggregated public sources), Axis Direct

Axis Direct

External broker reports(aggregated public sources)

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

Archean Chemical Industries / Equity Bottom-Up

<ul><li>Archean Chemical Industries Ltd (“ACI”) was incorporated on November 20, 2003.</li><li>Archean is a leading specialty marine chemical manufacturer in India and focused on producing and exporting Bromine, Industrial salt, and Sulphate of Potash to customers around the world.</li><li>Archean is the largest exporter of Bromine and industrial salt by volume in India in FY21 and has amongst the lowest cost of production globally in both Bromine and industrial salt.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Archean Chemical Industries Ltd (“ACI”) was incorporated on November 20, 2003.Archean is a leading specialty marine chemical manufacturer in India and focused on producing and exporting Bromine, Industrial salt, and Sulphate of Potash to customers around the world.Archean is the largest exporter of Bromine and industrial salt by volume in India in FY21 and has amongst the lowest cost of production globally in both Bromine and industrial salt.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Pick of the Week - Archean Chemical Industries Ltd - 18 MARCH 2024

<ul><li>Archean Chemical Industries Q3FY24 numbers surprised on all fronts, exceeding our expectations.</li><li>Consolidated Revenue at Rs 413 Cr, up by 13%/42% YoY/QoQ, beat our estimate by 39%.</li><li>EBITDA stood at Rs 145 Cr, higher on a QoQ basis (up -9%/52% YoY/QoQ), also surpassing our estimates by 34%. </li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Archean Chemical Industries Q3FY24 numbers surprised on all fronts, exceeding our expectations.Consolidated Revenue at Rs 413 Cr, up by 13%/42% YoY/QoQ, beat our estimate by 39%.EBITDA stood at Rs 145 Cr, higher on a QoQ basis (up -9%/52% YoY/QoQ), also surpassing our estimates by 34%. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Archean Chemical Industries Ltd - Strong Volume Beat in Industrial Salt Aided by Recovery in SOP

<ul><li>Archean Chemical Industries Limited (Archean or ACIL) is a leading Marine Chemical manufacturer from India engaged in the production and sale of Bromine (Br), Industrial Salt (NaCL), and Sulphate of Potash (K₂SO₄) from its leased brine reserves located in the Rann of Kutch, Gujarat.</li><li>ACIL has one of the largest integrated production facilitiesat Hajipur (Gujarat), which has a strategic proximity to Jakhau Jetty and Mundra Port, making exports easier and smoother.</li><li>The company plans to forward integrate its business in Bromine derivatives – an established extension followed across global major Bromine producers, into Flame Retardants, Clear Brine Fluids, and PTA Synthesis Catalyst. </li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Archean Chemical Industries Limited (Archean or ACIL) is a leading Marine Chemical manufacturer from India engaged in the production and sale of Bromine (Br), Industrial Salt (NaCL), and Sulphate of Potash (K₂SO₄) from its leased brine reserves located in the Rann of Kutch, Gujarat.ACIL has one of the largest integrated production facilitiesat Hajipur (Gujarat), which has a strategic proximity to Jakhau Jetty and Mundra Port, making exports easier and smoother.The company plans to forward integrate its business in Bromine derivatives – an established extension followed across global major Bromine producers, into Flame Retardants, Clear Brine Fluids, and PTA Synthesis Catalyst. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Archean Chemical - Specialty or Commodity Business? Our Take – a Special Commodity!

APAC IPOs & Placements, Aequitas Research

Clarence Chu

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/concord-biotech-ltd" target="_blank" data-smartkarma-citation="entities:36267:1" rel="noopener">Concord Biotech Ltd (658823Z IN)</a> raised US$188m in its India IPO.</li>
<li>Concord Biotech (Concord) is an India-based biopharma firm, which develops and manufactures fermentation-based active pharmaceutical ingredients (APIs).</li>
<li>In this note, we will talk about the trading dynamics.</li>
</ul>



Concord Biotech Ltd (658823Z IN) raised US$188m in its India IPO.
Concord Biotech (Concord) is an India-based biopharma firm, which develops and manufactures fermentation-based active pharmaceutical ingredients (APIs).
In this note, we will talk about the trading dynamics.


Concord Biotech IPO Trading - Strong Subscription Rates, Peers Have Moved up Since Last Note

<ul>
<li>
<a href="https://www.smartkarma.com/entities/concord-biotech-ltd" target="_blank" data-smartkarma-citation="entities:36267:1" rel="noopener">Concord Biotech Ltd (658823Z IN)</a> is looking to raise around US$188m in its India IPO.</li>
<li>Concord Biotech (Concord) is an India-based biopharma firm, which develops and manufactures fermentation-based active pharmaceutical ingredients (APIs).</li>
<li>In this note, we will undertake a peer comparison, and share our thoughts on valuation.</li>
</ul>



Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO.
Concord Biotech (Concord) is an India-based biopharma firm, which develops and manufactures fermentation-based active pharmaceutical ingredients (APIs).
In this note, we will undertake a peer comparison, and share our thoughts on valuation.


Concord Biotech IPO - Peer Comparison & Valuation - Smaller in Scale but Wider in Margins

India

Archean Chemical Industries is an Indian specialty marine chemical manufacturer, producing and exporting bromine, industrial salt, and sulphate of potash. The company utilizes brine from its reservoirs in the Rann of Kutch, Gujarat, for its integrated production facility. It was founded in 2003 and is headquartered in Chennai, Tamil Nadu, India.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Archean Chemical Industries (ACI IN)

Pick of the Week - Archean Chemical Industries Ltd - 18 MARCH 2024

Archean is the largest exporter of Bromine and industrial salt by volume in India in FY21 and has amongst the lowest cost of production globally in...

Axis Direct

Archean Chemical Industries Ltd - Strong Volume Beat in Industrial Salt Aided by Recovery in SOP

Archean Chemical Industries Q3FY24 numbers surprised on all fronts, exceeding our expectations. Consolidated Revenue at Rs 413 Cr, up by 13%/42%...

Axis Direct

Archean Chemical - Specialty or Commodity Business? Our Take – a Special Commodity!

ACIL has one of the largest integrated production facilitiesat Hajipur (Gujarat), which has a strategic proximity to Jakhau Jetty and Mundra Port,...

Axis Direct

Concord Biotech IPO Trading - Strong Subscription Rates, Peers Have Moved up Since Last Note

Concord Biotech Ltd (658823Z IN) raised US$188m in its India IPO. In this note, we will talk about the trading dynamics.

Clarence Chu

Concord Biotech IPO - Peer Comparison & Valuation - Smaller in Scale but Wider in Margins

Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. In this note, we will undertake a peer comparison, and share...

Clarence Chu

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)